Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.79 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | TGM2 | P21980 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.41 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.41 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.41 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1591868 | 1.00 | ZDHHC20 (0.79) | ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR | |
| SCHEMBL270209 | 1.00 | ZDHHC20 (0.79) | ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR | |
| SCHEMBL269468 | 1.00 | ZDHHC20 (0.79) | ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR | |
| SCHEMBL8405507 | 1.00 | ZDHHC20 (0.79) | ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR | |
| SCHEMBL1592093 | 1.00 | ZDHHC20 (0.79) | ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR | |
| SCHEMBL58169 | 1.00 | ZDHHC20 (0.79) | ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR | |
| SCHEMBL632264 | 0.97 | ZDHHC20 (0.75) | ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR | |
| SCHEMBL1561467 | 0.92 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR | |
| SCHEMBL24652920 | 0.91 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR | |
| SCHEMBL10777565 | 0.91 | ALDH1A1 (0.70) | ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180346629-A1 | Biocompatible polymers and co-polymers, and uses thereof | GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2018-12-06 | — | — | US | claimed |
| EP-0606742-B1 | Bile acid sequestrant | ROHM & HAAS (US) | 1997-11-19 | — | — | EP | claimed |
| EP-0425436-B1 | Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof | CIBA GEIGY AG (CH) | 1996-12-27 | — | — | EP | claimed |
| US-5519069-A | INTERPENETRATING POLYMER NETWORK, TWO CROSSLINKERS, PRECISION CASTING | PILKINGTON BARNES HIND, INC. (US) | 1996-05-21 | — | — | US | claimed |
| US-5451397-A | Crosslinked amino functional acrylic amide polymer, reducing blood cholesterol levels | ROHM AND HAAS COMPANY (US) | 1995-09-19 | — | — | US | claimed |
| EP-0606742-A1 | Bile acid sequestrant | ROHM AND HAAS COMPANY (US) | 1994-07-20 | — | — | EP | claimed |
| US-5079319-A | Contact Lenses | CIBA-GEIGY CORPORATION (US) | 1992-01-07 | — | — | US | claimed |
| EP-0425436-A2 | Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof | CIBA-GEIGY AG (CH) | 1991-05-02 | — | — | EP | claimed |
| US-4289695-A | REACTION OF A PHENICILLIN WITH AN N-CHLORO HALOGENATING AGENT IN PRESENCE OF A CROSSLINKED POLYVINYLPYRIDINE | ELI LILLY AND COMPANY (US) | 1981-09-15 | — | — | US | claimed |
| US-20230280332-A1 | Methods for Isolating Immune Binding Proteins | Augmenta Bioworks, Inc. (US) | 2023-09-07 | — | — | US | disclosed |
| US-11662341-B2 | Methods for isolating immune binding proteins | Augmenta Bioworks, Inc. (US) | 2023-05-30 | — | — | US | disclosed |
| US-20220380746-A1 | Methods for Making Gel Beads and Core and Shell Beads with a Cell | Augmenta Bioworks, Inc. (US) | 2022-12-01 | — | — | US | disclosed |
| EP-3941631-A1 | ISOLATION OF SINGLE CELLS AND USES THEREOF | Augmenta Bioworks, Inc. (US) | 2022-01-26 | — | — | EP | disclosed |
| US-20200385785-A1 | COMPOSITIONS AND METHODS FOR BARCODING | ROOTPATH GENOMICS, INC. | 2020-12-10 | — | — | US | disclosed |
| EP-0011370-B1 | PROCESS FOR PREPARING 2-CHLOROSULFINYL-AZETIDINONES | ELI LILLY AND COMPANY (US) | 1982-04-28 | — | — | EP | disclosed |
| US-4289695-A | REACTION OF A PHENICILLIN WITH AN N-CHLORO HALOGENATING AGENT IN PRESENCE OF A CROSSLINKED POLYVINYLPYRIDINE | ELI LILLY AND COMPANY (US) | 1981-09-15 | — | — | US | disclosed |
| EP-0015345-A1 | Process for preparing N-chloroimides | ELI LILLY AND COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |
| EP-0011370-A1 | Process for preparing 2-chlorosulfinyl-azetidinones | ELI LILLY AND COMPANY (US) | 1980-05-28 | — | — | EP | disclosed |
| US-4152508-A | OXYGEN PERMEABILITY, DIMENSIONAL STABILITY | POLYMER TECHNOLOGY CORPORATION (US) | 1979-05-01 | — | — | US | disclosed |
| US-3953408-A | LITHOGRAPHIC PLATES | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JA) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180346629-A1 | Biocompatible polymers and co-polymers, and uses thereof | ARG1, CRYAA, COL1A1 | ZDHHC20 3525/4885ZDHHC2 4217/4885ALDH1A1 2924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.